The Alere NMP22® Test Kit is an enzyme immunoassay (EIA) for the in vitro quantitative determination of the nuclear matrix protein NMP22 in stabilized voided urine.
The Alere Triage® System is a leading novel, rapid diagnostic test system comprised of a meter and various test devices that improve a physician’s ability to aid in the diagnosis of critical diseases and health conditions including heart failure and myocardial infarction as well as aid in assessing patients for pulmonary embolism. Alere Triage® brand rapid tests include quantitative BNP, CK-MB, d-dimer, myoglobin, NGAL, troponin I and qualitative TOX Drug Screen, and are currently used in approximately 70 percent of U.S. hospitals and is available in more than 50 international markets.